Completed NA INTERVENTIONAL 2-arm NCT02021903

Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies (HYPOSOMNPARK)

Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies: the Model of an Oral Glucose Load

Sponsor: Ministry of Health, France

Conditions Parkinsonian Disorders

Interventions V1: HGPO + meal and V2: placebo + meal V1: placebo 75mg + meal and V2: HGPO 75mg + meal

Updated 8 times since 2017 Last updated: Aug 24, 2020 Started: May 31, 2012 Primary completion: Dec 20, 2019 Completion: Jun 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02021903, this NA trial focuses on Parkinsonian Disorders and remains completed. Sponsored by Ministry of Health, France, it has been updated 8 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
May 2019 — Sep 2020 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Jun 2018 — May 2019 [monthly]

Recruiting NA
Mar 2017 — Jun 2018 [monthly]

Recruiting NA
Jan 2017 — Mar 2017 [monthly]

Recruiting NA

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Health, France
University Hospital, Toulouse

Data source: University Hospital, Toulouse

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bordeaux, France
• Toulouse, France